Captopril test: time over?
|
|
- Douglas Brooks
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Journal of Human Hypertension (1999) 13, Stockton Press. All rights reserved /99 $ T Lenz 1, T Kia 1, G Rupprecht 1, K-L Schulte 1,2 and H Geiger 1 1 Division of Nephrology, Medical Clinic IV, Johann Wolfgang Goethe University, Frankfurt am Main, Germany Objective: The role of non-invasive tests for the detection of renovascular hypertension is still a matter of controversy. The captopril test is widely used; its clinical usefulness, however, remains questionable. The aim of the current study was therefore to report our own experience and to review the published data on the diagnostic significance of the test. Patients and methods: Data from 485 hypertensive patients who underwent a captopril test in consecutive order at our institution were analysed retrospectively. After a 30-min resting period in the supine position 50 mg of captopril was given orally. Blood was collected before and 90 min after dosage for the determination of plasma renin concentration (normal range ng/ml/h). An increase by 100% or more of the baseline value was considered a positive response. Blood pressure was recorded at baseline and at 90 min. Results: A positive response was present in 62 patients; further diagnostic work-up revealed significant renal artery stenosis in 11 of these patients. In the 423 patients with a negative response renal artery stenosis was found in three cases. With some limitations of retrospective analyses in mind, sensitivity and specificity of the test were calculated as 79% and 89%, respectively. No severe complication occurred during the test. Conclusion: Our data on the diagnostic indices and the safety of the captopril test are in good agreement with most published series. Altogether, available data suggest that the captopril test has a limited diagnostic accuracy as a screening test for the detection of renovascular hypertension. New radiologic non-invasive techniques with greater diagnostic value are therefore likely to challenge the clinical role of the test in the future. Keywords: captopril test; renovascular hypertension; magnetic resonance imaging; computerised tomography angiography Introduction Renovascular hypertension is the most frequent form of secondary hypertension, although its precise prevalence is not known. Several competing noninvasive diagnostic procedures have been proposed but there is no generally accepted consensus on how to proceed in patients with suspected renovascular disease. Case and Laragh 1 were the first to show that the reactive rise of plasma renin after an angiotensin converting enzyme (ACE) inhibitor is greater in patients with renovascular hypertension than with essential hypertension. This observation led to the introduction of the so-called captopril test for the diagnostic work-up of patients with suspected renovascular hypertension. At first quite enthusiastic results with high sensitivity (up to 100%) and specificity were reported 2 ; subsequent studies, however, found lower diagnostic accuracy. It has been suggested that the differences in the reported accuracy may be attributable to several factors such as the renin assay method used, varying criteria for defining renovascular hypertension, sodium restriction and position of the patient during the test (for review see reference 3). A decade ago Gaul and Correspondence: Dr Tomas Lenz, Division of Nephrology, Medical Clinic IV, Johann Wolfgang Goethe University, Theodor Stern Kai 7, Frankfurt am Main, Germany 2 Current address: Medical Clinic, Königin Elisabeth Hertberge Hospital, Berlin Received 26 October 1998; accepted 22 January 1999 coworkers 4 searched the published studies on the captopril test and selected 16 of them for further analysis according to certain quality criteria. At that time these authors concluded that the clinical usefulness of the test cannot be assessed on the basis of the existing data since clear cut-off points were not defined and the test results were not always confirmed by arteriography. Therefore, in the current paper the literature of the ensuing 10 years including our own experience is presented in order to answer the question whether we have gained important new insights on the usefulness of the captopril test in the last decade. Patients and methods Patients Medical records from 485 patients (242 female, 243 male; mean age 44.7 ± 13.3 (range 10 81) years) with suspected renovascular hypertension who in consecutive order underwent a captopril test at our institution from 1991 through 1993 were reviewed. According to the available blood pressure measurements in the patient charts prior to the testing (total n = 457) 43% of the patients were borderline hypertensive (sitting diastolic blood pressure mm Hg), 50% were moderately hypertensive (sitting diastolic blood pressure mm Hg) and 7% were severely hypertensive (sitting diastolic blood pressure 115 mm Hg).
2 432 Captopril testing procedure Diuretics and ACE inhibitors were discontinued at least 1 week before testing; if possible no antihypertensive medication was given 12 h prior to testing. Patients were advised to maintain a normal salt intake. After a 30-min resting period in the supine position 50 mg of captopril was given orally with some tap water. Blood (10 ml) was collected and placed on ice before and 90 min after dosing for the determination of plasma renin concentration. An increase by 100% or more of the baseline value was considered a positive response. Blood pressure was recorded at baseline and at 90 min. Plasma renin concentration was determined with a variation to the method by Boucher et al, 5 using nephrectomized sheep renin substrate (normal range ng/ml/h). Statistical analysis The results are given as mean ± s.e.m. Wilcoxon Mann Whitney statistics were used for comparisons between groups. P-values 0.05 were considered significant. Results Renin response/diagnostic indices In the whole group plasma renin concentration amounted to 6.2 ± 3.0 ng/ml/h at baseline and increased to 10.3 ± 10.2 ng/ml/h 90 min after captopril with a large scatter in the data (P 0.001). A positive response after captopril according to the test criteria was present in 62 patients. In this group plasma renin concentration increased from a baseline value of 9.2 ± 4.8 ng/ml/h to 28.8 ± 18.3 ng/ml/h after captopril (P 0.001). Further diagnostic workup by arteriography revealed significant renal artery stenosis (at least 50% narrowing of at least one renal artery) in 11 of these patients. In the 423 patients with a negative captopril response renal artery stenosis was found in three cases; arteriography, however, was not performed in all patients. With these limitations in mind sensitivity and specificity of the test were calculated as 79% and 89%, respectively. The prevalence of renal artery stenosis was 2.4% in patients with borderline and moderate hypertension compared to 11.8% in severely hypertensive patients. Blood pressure response after captopril Mean arterial pressure (1/3 (P sys P dia ) + P dia ) in the group with a positive response decreased from 111 ± 3to99 ± 3 mm Hg which was a significantly greater drop than in the group with a negative response (P 0.01) where the respective values were 114 ± 14 and 106 ± 16 mm Hg. Other diagnoses Clinical follow-up showed that 15 patients of the captopril-positive group were later normotensive and in one patient renal parenchymal hypertension was diagnosed. In the captopril-negative group seven patients were diagnosed having primary hyperaldosteronism and one patient had pheochromocytoma. In nine patients of this group hypertension was attributed to renal insufficiency. Normotensive blood pressure values were later obtained in 65 patients of this group. Renal function Twenty-one of the patients had a plasma creatinine value 1.5 mg/dl. The test was negative in 19 patients. In one of them renal artery stenosis was found. One patient of this group had a false positive captopril response. Complications No severe complication occurred during the test. Discussion Non-invasive tests for the detection of renovascular hypertension are needed since the prevalence of the disease in the general hypertensive population is low. In the past essentially three tests have been used as a screening test: renal scintigraphy following captopril administration (captopril renography), duplex scanning and the captopril test; each of them has its own advantages and disadvantages. The role of the captopril test for the diagnosis of renovascular hypertension has been controversial for several reasons: Renovascular hypertension vs renal artery stenosis A more general concern is that the term renal artery stenosis is not synonymous for renovascular hypertension. One has to take into consideration that a pure anatomical diagnosis of renal artery narrowing by whatever means does not necessarily prove the existence of renovascular hypertension. In other words the haemodynamic significance of a renal artery stenosis is hard to predict. Some authors require an angiographic stenosis of at least 70 to 75% to make the diagnosis, 6 8 whereas others use a cut-off of 50% narrowing. 9 Functional data, however, are usually not provided in most published series on any diagnostic procedure for the disease. With some limitations the most widely accepted functional criterion is cure or improvement (reduced number of antihypertensive medications) of hypertension after revascularisation, information that rarely is provided. Heterogeneity of the disease The picture of renal artery stenosis is extremely heterogeneous with regard to pathogenesis (atherosclerotic, fibromuscular etc), anatomy (unilaterlal, bilateral, solitary kidney, renal transplant), localisation (ostial, proximal, distal etc) and coexisting conditions (eg, renal insufficiency). It has been shown that the renin response after captopril
3 depends on these factors, eg, it is less evident in most cases with bilateral disease, in patients with renal insufficiency, younger age and in blacks. 3,10 Furthermore, ischaemic nephropathy with or without stenosis of the main renal artery or its branches has only recently been recognised as a clinical entity that shares functional properties with renovascular disease. Ischaemic nephropathy is often seen in diabetics and in patients with connective tissue disorders. 11 In these patients the renin response after captopril may be similar to patients with renovascular disease due to intrarenal small vessel abnormalities, even in the abscence of stenosis of the main renal artery or its branches. A higher prevalence of ischaemic nephropathy due to small vessel disease may therefore partly be responsible for a higher rate of false positive test results. Limited diagnostic accuracy There is a large variation in the published data on the diagnostic accuracy of the test, with results on sensitivity ranging from 40 to 100% and on specificity from 72 to 100%. 3 In the special group of renal transplant recipients a sensitivity of 75% and a specificity of 67% was found after 25 mg of captopril. 12 The prevalence of the disease in the cohort to be studied influences the diagnostic value of a test. 10,13 A higher rate of false positive results may therefore be obtained if patients with high renin essential hypertension with an exaggerated renin response after ACE inhibition are studied who per definition have a low probability for renovascular disease. 14 On the other hand when a hypertensive population with a high level of clinical suspicion for renovascular hypertension is investigated the captopril test does not discriminate appropriately between patients with essential and renovascular hypertension. 15 The prevalence of the disease in our own patients was only 3% which reflects the situation in the general hypertensive population probably quite well. Our study demonstrates that as can be expected almost 50 tests have to be performed to identify one patient with renal artery stenosis when a more general hypertensive population with a natural prevalence is investigated. Another reason for the divergent results may be the fact that most groups use their own protocol and that there is no generally accepted instruction on how to proceed. Harmonisation and standardisation, however, appear to be prerequisites for a meaningful interpretation of the results and a comparison between the various studies. Standardisation includes cessation of antihypertensive therapy, salt diet and food intake before the test, position during the testing and a valid renin assay. Table 1 attempts to give an overview on the studies that were published in the last decade (except renal transplant patients). It is obvious that various protocols and different diagnostic criteria are still being applied. Not surprisingly, similar to studies of the 1980s divergent results were obtained with respect to diagnostic accuracy of the test. If every group uses his own protocol, validation of the test criteria needs to be ensured by angiography-controlled prospective data rather than by post hoc adjustments, a criticism that also applies to our own study. It is hard to say whether such an expenditure is really justified or whether other ways can be found. Competing tests Other ways appear on the horizon since newer angiographic technologies that are only minimally invasive compete with the test. Spiral computerised tomography angiography (CTA) and magnetic resonance angiography (MRA) of the renal artery provide fascinating pictures and these technologies are currently being investigated in such patients. The introduction of paramagnetic contrast-media almost revolutionises the diagnostic reliability of MRA since now the problem of missed accessory renal arteries is mostly overcome. The current published reports suggest that a normal MRA is highly indicative for normal renal arteries, virtually abolishing the risk of false negative readings. 24 In addition, the method provides the possibility for the measurement of single kidney blood flow and filtration rate in the course of a single procedure. 25,26 A recent editorial comment concluded that it is very likely that MRA will replace all other diagnostic procedures for detection of renal artery stenosis. 27 In patients with normal renal function spiral CTA with intravenous contrast media appears to be a good alternative since the diagnostic accuracy is similar to MRA. 28,29 Due to the required high volume of contrast media it is usually not recommended for patients with renal function impairment. 27 The role of duplex scanning and captopril renography has extensively been discussed in previous publications. 3,10,30,31 Risks The captopril test has some risks which essentially are related to an overshooting blood pressure response. One report acclaims that 15% of the patients tested experienced reversible cerebral symptoms, 18 possibly due to the high prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. 32 Other authors state that the test is well tolerated... and easy to perform. 7 Slightly anecdotal is the notion that it was occasionally necessary to place the patient in the supine position and to initiate a saline infusion. 2 It is obvious that the true rate of complications is hard to assess since the published data are not coherent in this regard and certainly far from complete. Also, the captopril doses used are not identical nor are other test variables (Table 1), eg, seated or supine position. Altogether, the test is certainly not without any risks. Costs Last but not least cost efficacy of a test should be taken into consideration. Blaufox and coworkers 33 performed a meta-analysis on various diagnostic tests comparing sensitivity and specificity, which were used to project cost per patient cured or 433
4 434 Table 1 Characteristics of studies for the use of captopril in the diagnosis of renovascular hypertension published in the last decade First author All pts/rvh pts Medication/mg Positive test criteria Arteriography- Sensitivity Specificity Prevalence (%) captopril for renin response confirmed (%) (%) Davidson 16 36/25 (69) discontinued/50 # post 5.7 ng/ml/h yes Degenhardt /24 (21) discontinued/0.5 mg/kg pre 2.0, post # yes ng/ml/h Frederickson 7 100/29 (29) discontinued/50 post 5.7 ng/ml/h yes Gosse 8 103/11 (10) partially maintained/50 + yes Hansen 18 47/11 (23) discontinued/ ## yes Idrissi 19 62/12 (19) discontinued/*** **yes Iwaoka /18 (9) discontinued/50 post 10.6 ng/ml/h yes Kutkuhn /44 (37) *maintained/25 posterior probability yes Postma 9 149/44 (30) discontinued/25 increase 16 ng/ml/h yes Schreij 15 46/20 (43) discontinued/25 ROC yes ROC ROC Svetkey 22 66/11 (17) discontinued/25 4 ng/ml/h **yes Takata 23 50/28 (56) discontinued/25 post 16 ng/ml/h yes *Except diuretics and ACE-inhibitors; **i.v. DSRA; ***sequential dosage, dependent on blood pressure response. # Post captopril value only available; # only when captopril test or i.v. DSA was positive; ## only when 131 -l-hippuran isotopic renography was positive; +various criteria according to Muller et al 2 ; ++increase not specified; only 2 days before test; receiver operator characteristic curves. improved for each modality. They found that the Doppler and the captopril test were less cost-effective than captopril renography and arteriography. To our knowledge no such comparative analysis exists for the new angiographic technologies. Presently, the cost of MRA is still too high to recommend it as a general screening method for hypertensive patients, restricting its use to patients with a high clinical suspicion for the disease. If a cost reduction is possible the outstanding diagnostic potential of the method is likely to pave the way for a broader application in patients with suspected renovascular hypertension. 27 Almost a decade ago a cautionary note concluded that the captopril test has a number of weaknesses; nevertheless, the commentators expressed their hope that the test should prove to be a very useful diagnostic tool in selected patients. 34 Approaching the year 2000 a critical evidence-based analysis in our opinion would rather suggest that for reasons exclaimed above, the test is not accurate and not simple enough to play an important role in the diagnostic work-up of even selected patients with suspected renovascular disease in the future. We believe its time is over since better tools have become available. Acknowledgements This work was supported by the Dr Bodo Sponholz Stiftung, Frankfurt am Main. The authors thank Mrs Astrid Mösbauer for measuring the plasma renin concentration. Parts of this study were presented in abstract form at the Annual Meeting of the German Hypertension League (Dreiländertreffen), Freiburg, Germany, References 1 Case DB, Laragh JH. Reactive hyperreninemia in renovascular hypertension after angiotensin blockade with saralasin or converting enzyme inhibitor. Arch Intern Med 1979; 91: Muller FB et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986; 80: Pickering TG, Mann SJ. Renovascular hypertension: medical evaluation and nonsurgical treatment. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven: New York, 1995, pp Gaul MK, Linn WD, Mulrow CD. Captopril-stimulated renin secretion in the diagnosis of rnovascular hypertension. Am J Hypertens 1989; 2: Boucher R, Veyrat R, de Champlain J, Genest J. New procedures for measurement of human plasma angiotensin and renin activity levels. Canad Med Ass J 1964; 90: Pickering TG et al. Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful renal angioplasty. Am J Med 1985; 76: Frederickson ED et al. A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension. Arch Intern Med 1990; 150: Gosse P et al. Captopril test in the detection of renovascular hypertension in a population with low prevalence of the disease. A prospective study. Am J Hypertens 1989; 2: Postma CT et al. The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med 1990; 150: Mann SJ, Pickering T. Detection of renovascular hypertension. Ann Intern Med 1992; 117: Sos TA, Trost DW. Renal vascular disease as a cause of hypertension. Curr Opin Nephrol Hypertens 1995; 4: Erley CM et al. Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients a prospective analysis. Transplantation 1992; 54: Pickering TG. Diagnosis and valuation of renovascular hypertension. Circulation 1991; 83 (Suppl I): I-147 I Gerber LM et al. Response to the captopril test is dependent on baseline renin profile. J Hypertens 1994; 12: Schreij G et al. Captopril test with blood pressure and peripheral renin as response variables in hypertensive
5 patients with suspected renal artery stenosis. J Hum Hypertens 1995; 9: Davidson RA, Barri YM, Wilcox CS. The simplified captopril test: an effective tool to diagnose renovascular hypertension. Am J Kidney Dis 1994; 24: Degenhardt S et al. The value of the captopril test in the work-up of hypertension. Klin Wochenschr 1989; 67: Hansen PB, Garsdal P, Fruergaard P. The captopril test for identification of renovascular disease: value and immediate adverse effects. J Intern Med 1990; 228: Idrissi A et al. The captopril challenge test as a screening test for renovascular hypertension. Kidney Int 1988; 34 (Suppl 25): S138 S Iwaoka T et al. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension. Am J Hypertens 1993; 6: Kutkuhn B et al. Validity of the captopril test for identifying correctable unilateral renovascular hypertension. Clin Exp Hyper A 1991; A13: Svetkey LP et al. Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension 1989; 14: Takata M et al. Diagnostic value of captopril test in hypertensive patients with renal artery stenosis. Angiology 1994; 45: Cobelli FD et al. Renal artery stenosis: value and screening with three-dimensional phase-contrast MR angiography with a phased-array multicoil. Radiology 1996; 201: Wolf RL et al. Measurement of normal renal blood flow: cine phase-contrast MR imaging vs clearance of p-aminohippurate. Am J Roentgenol 1993; 161: Ros PR et al. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentate-based measurements of glomerular filtration rate. Am J Roentgenol 1995; 165: Olbricht CJ, Arlart IP. (Editorial comment). Magnetic resonance angiography the procedure of choice to diagnose renal artery stenosis? Nephrol Dial Transplant 1998; 13: Galanski M et al. Renal artery stenoses: spiral CT angiography. Radiology 1993; 189: Olbricht CJ et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int 1995; 48: Mann SJ et al. Captopril renography in the diagnosis of renal artery stenosis. Accuracy and limitations. Am J Med 1991; 90: Spies KP et al. Color-coded duplex sonography for non-invasive diagnosis and grading of renal artery stenosis. Am J Hypertens 1995; 8: Missouris CG et al. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant 1998; 13: Blaufox MD, Middleton ML, Bongiovanni J, Davis BR. Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 1996; 37: McCarthy JE, Weder AB. (Editorial). The captopril test and renovascular hypertension. A cautionary tale. Arch Intern Med 1990; 150:
A Closer Look: Renal Artery Stenosis. Renal artery stenosis (RAS) is defined as a TOPICS FROM CHEP. Shawn s stenosis
TOPICS FROM CHEP A Closer Look: Renal Artery Stenosis On behalf of the Canadian Hypertension Education Program (CHEP), Dr. Tobe gives an overview of renal artery stenosis, including the prevalence, screening
More informationRenal artery stenosis
Renal artery stenosis Dr. Alexander Woywodt Consultant Renal Physician, Royal Preston Hospital Preston, 31.10.2007 Menu anatomy of the renal arteries diseases of the large renal arteries atherosclerotic
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationMultislice CTA for Renal Artery Stenting
Multislice CT for Renal rtery Stenting How CT can be a useful modality for diagnosing and managing renal artery stenosis for stent placement. Y MICHEL WHOLEY, MD, M; JMES WU, ; WILLIM C.L. WU, MD, FCC;
More informationEvaluation of Colour Duplex Ultrasound Scanning in Diagnosis of Renal Artery Stenosis, Compared to Angiography: A Prospective Study on 53 Patients
Eur J Vasc Endovasc Surg 14, 305-309 (1997) Evaluation of Colour Duplex Ultrasound Scanning in Diagnosis of Renal Artery Stenosis, Compared to Angiography: A Prospective Study on 53 Patients M. Mollo,
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationEffective Health Care
Number 5 Effective Health Care Comparative Effectiveness of Management Strategies for Renal Artery Stenosis Executive Summary Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen
More informationDiagnosis of Renal Artery Stenosis (RAS)
May 2001 Diagnosis of Renal Artery Stenosis (RAS) Kurt Fink, Harvard Medical School, Year III Epidemiology Hypertension -Affects 60 million Americans Essential HTN >95% of cases Secondary HTN 1-5% of cases
More informationRenovascular hypertension in children and adolescents
Renovascular hypertension in children and adolescents M I E C Z Y S L AW L I T W I N D E P T. O F N E P H R O LO G Y & A R T E R I A L H Y P E R T E N S I O N T H E C H I L D R E N S M E M O R I A L H
More informationDr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationUS of Renovascular Hypertension. Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging
US of Renovascular Hypertension Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging Disclosures Nothing Relevant Unrelated grant funding Siemens US Toshiba US Objectives
More informationSecondary Hypertension: A Real World Approach
Secondary Hypertension: A Real World Approach Evan Brittain, MD December 7, 2012 Kingston, Jamaica Disclosures None Real World Causes Renovascular Hypertension Endocrine Obstructive Sleep Apnea Pseudosecondary
More informationRenal Artery Stenosis With Severe Hypertension: A Case Report
CASE REPORT Renal Artery Stenosis With Severe Hypertension: A Case Report Suwaid MA ABSTRACT Background: Renal artery stenosis (RAS) is found in 77% of hypertensive patients and is responsible for 1-2%
More informationHYPERTENSION affects. Advances in noninvasive screening for renovascular disease
Advances in noninvasive screening for renovascular disease JOSEPH V. NALLY, JR., MD; JEFFREY W. OLIN, DO; GARY K. LAMMERT, MD BACKGROUND Nearly 50 million Americans have hypertension, and renovascular
More informationDeakin Research Online
Deakin Research Online This is the published version: MacGinley, Rob and Mangos, George 2010, Renal artery stenosis and hypertension: whom and how to screen and treat, Medicine today, vol. 11, no. 2, pp.
More informationRenal. Prof John Buscombe
Renal Prof John Buscombe Renal nuclear Medicine Only consistent test of kidney func7on Many good tests for renal anatomy Ultrasound good looking at cysts and renal pelvis CT can look at perfusion, size
More informationUrinary Kallikrein Excretion in Hypertensive Man
Urinary Kallikrein Excretion in Hypertensive Man RELATIONSHIPS TO SODIUM INTAKE AND SODIUM-RETAINING STEROIDS By Harry S. Margolius, David Horwttz, John J. Pisano, and Harry R. Kelser ABSTRACT Urinary
More informationUse of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension
Kidney International, Vol. 44 (1993), PP. 1379 139 NEPHROLOGY FORUM Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension Principal discussant: CHRISTOPHER S. WILCOX
More informationOstial Stents and Distal Embolic Protection During Renal Stenting
Ostial Stents and Distal Embolic Protection During Renal Stenting John R. Laird, MD Professor of Medicine Director of the Vascular Center UC Davis Medical Center Limitations of Current Techniques of Renal
More informationProf. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.
What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek
More informationCT Versus MR for the Runoff
CT Versus MR for the Runoff Robert R. Edelman, M.D. Dept. of Radiology NorthShore University HealthSystem Feinberg School of Medicine, Northwestern University Magnetic Resonance Computed Tomography Radio
More informationScreening tests for diagnosis of renal artery stenosis
218..226 NEPHROLOGY 2010; 15, S218 S226 doi:10.1111/j.1440-1797.2009.01244.x Screening tests for diagnosis of renal artery stenosis Date written: December 2008nep_1244 Final submission: June 2009 Authors:
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationFibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options
Fibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options Poster No.: C-0630 Congress: ECR 2012 Type: Educational Exhibit Authors: K. I. Ringe, B. Meyer, F. Wacker,
More informationPrimary Aldosteronism: screening, diagnosis and therapy
Primary Aldosteronism: screening, diagnosis and therapy Jacques W.M. Lenders, internist DEPT. OF INTERNAL MEDICINE, RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTER, NIJMEGEN,THE NETHERLANDS DEPT. OF INTERNAL
More informationADRENAL VEIN SAMPLING: AN INTEGRAL PART OF MANAGING COMPLICATED ADRENAL HYPERTENSION- SAFE? WORTH IT?
ADRENAL VEIN SAMPLING: AN INTEGRAL PART OF MANAGING COMPLICATED ADRENAL HYPERTENSION- SAFE? WORTH IT? Chaitanya Ahuja, M.D. Assistant Professor, Vascular and Interventional Radiology Director of Interventional
More informationPrediction of Tubulo Interstitial Injuries by Doppler Ultrasound in Patients with Glomerular Disease: Value of Resistive Index and Atrophic Index
International Journal of Scientific and Research Publications, Volume 5, Issue 8, August 2015 1 Prediction of Tubulo Interstitial Injuries by Doppler Ultrasound in Patients with Glomerular Disease: Value
More informationNatural history and progression of atherosclerotic renal vascular stenosis
204..209 NEPHROLOGY 2010; 15, S204 S209 doi:10.1111/j.1440-1797.2009.01242.x Natural history and progression of atherosclerotic renal vascular stenosis Date written: December 2008nep_1242 Final submission:
More information1. How did occlusion of Mr. Hanna's left renal artery lead to an increase in plasma renin activity?
76 I'HYSIOLOGY CASES AND PROBLEMS Case 14 Renovascular Hypertension: The Renin-Angiotensin-Aldosterone System Stewart Hanna is a 58-year-old partner in a real estate firm. Over the years, the pressures
More informationDIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING
DIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING Harold Thomas Pretorius, MD, PhD, Nichole Richards, and Michael Harrell Abstract Objective: A new method using a nuclear
More informationMeasure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care
Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE:
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationUltrasound of the Renal Arteries
Ultrasound of the Renal Arteries Greg Curry Vascular Ultrasound Workshop Aug 2017 The Examination Technique Pathophysiology Role of US then and now Background Live Scanning Ultrasound Population: 20% Hypertensive
More informationNOT FOR PUBLICATION, QUOTATION, OR CITATION RESOLUTION NO. 22
BE IT RESOLVED, Sponsored By: RESOLUTION NO. 22 that the American College of Radiology adopt the ACR SIR Practice Parameter for the Performance of Angiography, Angioplasty, and Stenting for the Diagnosis
More informationQuality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care
Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationThe major issues in approaching patients with renal artery stenosis
Renovascular Hypertension and Ischemic Nephropathy Marc A. Pohl The major issues in approaching patients with renal artery stenosis relate to the role of renal artery stenosis in the management of hypertension,
More informationAdrenal Vein Sampling: A Critical Tool for Subtyping Primary Aldosteronism
Adrenal Vein Sampling: A Critical Tool for Subtyping Primary Aldosteronism Disclosures No conflicts of interest relevant to this presentation Jason W. Pinchot, M.D. Assistant Professor, Vascular and Interventional
More informationImaging for Peripheral Vascular Disease
Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right
More informationRenovascular hypertension
Kidney International, Vol. 27 (1985), pp. 811 827 NEPHROLOGY FORUM Renovascular hypertension Principal discussant: E. DARRACOTT VAUGHAN, JR. The New York Hospital-Cornell Medical Center, New York, New
More informationPeripheral Arterial Disease: Who has it and what to do about it?
Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%
More informationDisclosure of Potential Conflicts. Renal Artery Stenosis. RAS Epidemiology. Road Map. Background. ASDIN 7th Annual Scientific Meeting
Renal Artery Stenosis Disclosure of Potential Conflicts Cytopherx, Inc. R4 Vascular, Inc. Bard Peripheral Vascular Spectranetics, Inc. Alexander S. Yevzlin, MD Associate Professor of Medicine (CHS) ASDIN
More informationLife After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention
Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention No Relationships to Disclose The Need for Modern Renal Trials Increased rate of RAS diagnosis
More informationRAS Epidemiology. Renal Artery Stenosis. Pathophysiology of RAS. Disclosure of Potential Conflicts. Background Pathophysiology of RAS.
Renal Artery Stenosis RAS Epidemiology Common Disease Incidence General Population 0.1% Hypertensive Population 4% HTN & Suspected CAD 10-20% Malignant HTN 20-30% Malignant HTN and CKD 30-40% Alexander
More informationIschemic nephropathy: Detection and therapeutic intervention
Kidney International, Vol. 68, Supplement 99 (2005), pp. S131 S136 Ischemic nephropathy: Detection and therapeutic intervention JOSÉ A. GARCíA-DONAIRE and JOSÉ M. ALCÁZAR Department of Nephrology, Hospital
More informationTreating Hypertension from
Treating Hypertension from Initiation to Resistance: A Case Study Approach Michelle Krause, MD Division of Nephrology University of Arkansas for Medical Sciences Central Arkansas Veteran s Healthcare System
More informationRole of the Radiologist
Diagnosis and Treatment of Blunt Cerebrovascular Injuries NORDTER Consensus Conference October 22-24, 2007 Clint W. Sliker, M.D. University of Maryland Medical Center R Adams Cowley Shock Trauma Center
More informationRenal artery stenosis is the most common cause of secondary hypertension. Over 90% of renal
General cardiology ARTERIOSCLEROTIC RENAL ARTERY STENOSIS: CONSERVATIVE VERSUS INTERVENTIONAL MANAGEMENT c RENAL Additional references appear on the Heart website Correspondence to: Priv. Doz. Dr C Haller,
More informationA CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES
A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE Maricel Pilapil-Pureza WLA Nephrology OBJECTIVES After the presentation, the attendee will be able to: 1. Discuss when to suspect for secondary causes of
More informationAlthough moyamoya disease, a rare cerebrovascular occlusive
Renal Artery Lesions in Patients With Moyamoya Disease Angiographic Findings Ichiro Yamada, MD; Yoshiro Himeno, MD; Yoshiharu Matsushima, MD; Hitoshi Shibuya, MD Background and Purpose Renal artery lesions
More informationCOMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan
Rotazar (Film coated tablets) Irbesartan Rotazar 75 mg, 150 mg, 300 mg COMPOSITION A film coated tablet contains Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar 75 mg, 150 mg, 300 mg PHARMACOLOGICAL
More informationDeborah K. Mann & Jennifer Bash. Coding Documentation and Education Managers
Deborah K. Mann & Jennifer Bash Coding Documentation and Education Managers OBJECTIVES Review the basics of Diagnostic, CT, & MRI documentation Risk areas in radiology associated with Diagnostic, CT, &
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationIndex. Note: Page numbers of article titles are in boldface type.
Magn Reson Imaging Clin N Am 12 (2004) 587 591 Index Note: Page numbers of article titles are in boldface type. A Adenoma(s), adrenal, gadolinium-enhanced MR imaging in, 533 534 hyperfunctioning versus
More informationHow to assess the hemodynamic importance of a renal artery stenosis. Felix Mahfoud, MD Saarland University Hospital Homburg/Saar, Germany
How to assess the hemodynamic importance of a renal artery stenosis Felix Mahfoud, MD Saarland University Hospital Homburg/Saar, Germany How to assess renal artery stenosis severity 1. Non-invasive assessments
More informationSpiral CT angiography-can we forget about arteriography to diagnose renal artery stenosis?
Nephrol Dial Transplant ( 1996) 11: Editorial Comments 1227 Spiral CT angiography-can we forget about arteriography to diagnose renal artery stenosis? C. J. Olbricht 1, M. Galanski 2, A. Chavan 2 and M.
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationAtherosclerotic renovascular disease
Cardiology 69 Atherosclerotic renal artery stenosis Atherosclerotic renal artery stenosis is largely a disease of the elderly and is commonly associated with hypertension and renal dysfunction. Blood pressure
More informationUpon completion, participants should be able to:
Learning Objectives Upon completion, participants should be able to: Describe the causes of secondary hypertension and the prevalence of primary aldosteronism Discuss the diagnostic approach to primary
More informationAtherosclerotic renal artery stenosis and reconstruction
http://www.kidney-international.org & 2006 International Society of Nephrology mini review Atherosclerotic renal artery stenosis and reconstruction B Krumme 1 and J Donauer 2 1 Deutsche Klinik für Diagnostik,
More informationRenal Artery Stenting
Renal Artery Stenting J.P. Reilly, MD, FSCAI Ochsner Medical Center Speaker s bureau: Astra Zeneca and Lilly/Diachi Sankyo Prevalence of RAS is high in cath population. Renal artery intervention can help
More informationRadiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography
CME Article Radiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography Esther S. H. Kim, MD, MPH, Megan Thompson, Kristine M. Nacion, BA, Carmel Celestin,
More informationHyperaldosteronism: Conn's Syndrome
RENAL AND ACID-BASE PHYSIOLOGY 177 Case 31 Hyperaldosteronism: Conn's Syndrome Seymour Simon is a 54-year-old college physics professor who maintains a healthy lifestyle. He exercises regularly, doesn't
More informationHYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
More informationRenal Artery Stenosis: Insights from the CORAL Trial
Renal Artery Stenosis: Insights from the CORAL Trial Christopher J. Cooper, M.D., FACC, FACP Dean and Senior Vice President University of Toledo, College of Medicine President, Ohio Chapter ACC State of
More informationDr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.
The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,
More informationKEY WORDS: Bilateral Renal Artery Stenosis, Cardiac Catherization, Incidental Findings, Associated Co- morbidity
BILATERAL RENAL ARTERY STENOSIS - AN INCIDENTAL FINDING DURING CARDIAC CATHETERIZATION Review of 15 Cases of BRAS Stenting at Queen Alia Heart Institute in Jordan Hatem Hamdan Salaheen Abbadi 1 ABSTRACT:
More informationBlunt Carotid Injury- CT Angiography is Adequate For Screening. Kelly Knudson, M.D. UCHSC April 3, 2006
Blunt Carotid Injury- CT Angiography is Adequate For Screening Kelly Knudson, M.D. UCHSC April 3, 2006 CT Angiography vs Digital Subtraction Angiography Blunt carotid injury screening is one of the very
More informationA Case Report of Acute Renal Artery Occlusion Mimicking Acute Appendicitis
ISPUB.COM The Internet Journal of Surgery Volume 7 Number 1 A Case Report of Acute Renal Artery Occlusion Mimicking Acute Appendicitis S Abouel-Enin, A Douglas, R Morgan Citation S Abouel-Enin, A Douglas,
More informationImaging of Renovascular. Scintigraphy, Renal Doppler US, and MR Angiography 1
SCIENTIFIC EXHIBIT 1355 Imaging of Renovascular Hypertension: Respective Values of Renal Scintigraphy, Renal Doppler US, and MR Angiography 1 CME FEATURE See accompanying test at http:// www.rsna.org /education
More informationSerum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease
Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationPlasma Renin Activity and Renin-Substrate Concentration in Patients with Liver Disease
Plasma Renin Activity and Renin-Substrate Concentration in Patients with Liver Disease By Carlos R. Ayers, M.D. ABSTRACT Peripheral venous renin activity was determined by the method of Boucher in 15 patients
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ABI. See Ankle-brachial index (ABI). Afterload, deconstructing of, in ventricular vascular interaction in heart failure, 449 Air plethysmography
More informationOutcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting
Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting Xue F Y, Bettmann M A, Langdon D R, Wivell W A Record Status
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationMajor improvements in imaging, medical therapy, and
Contemporary Reviews in Cardiovascular Medicine Renovascular Hypertension and Ischemic Nephropathy Vesna D. Garovic, MD; Stephen C. Textor, MD Major improvements in imaging, medical therapy, and techniques
More informationNuclear medicine methods in the urogenital system
Nuclear medicine methods in the urogenital system Anatomy of the kidneys I. Anatomy of the kidneys II. The types of examinations Static examinations (scintigraphy): 1) the radiopharmaceutical is administered
More informationA Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery
doi: 10.2169/internalmedicine.0023-17 Intern Med 57: 2689-2694, 2018 http://internmed.jp CASE REPORT A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery Ikki
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationTransducer Selection. Renal Artery Duplex Exam. Renal Scan. Renal Scan Echogenicity. How to Perform an Optimal Renal Artery Doppler Examination
How to Perform an Optimal Renal Artery Doppler Examination Director of Ultrasound Education & Quality Assurance Baylor College of Medicine Division of Maternal-Fetal Medicine Maternal Fetal Center Imaging
More informationV.A. is a 62-year-old male who presents in referral
, LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.
More informationIndex. mri.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Angiogenesis, and cancer of prostate, 689 690 Angiography, MR. See MR angiography. Apoptosis, MR imaging of, 637 Apparent diffusion coefficient,
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review consultation document Review of Clinical Guideline (CG95) Chest pain of recent onset: Assessment and diagnosis
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationYear 2004 Paper two: Questions supplied by Megan 1
Year 2004 Paper two: Questions supplied by Megan 1 QUESTION 96 A 32yo woman if found to have high blood pressure (180/105mmHg) at an insurance medical examination. She is asymptomatic. Clinical examination
More informationGUNDERSEN/LUTHERAN ULTRASOUND DEPARTMENT POLICY AND PROCEDURE MANUAL
GUNDERSEN/LUTHERAN ULTRASOUND DEPARTMENT POLICY AND PROCEDURE MANUAL SUBJECT: Carotid Duplex Ultrasound SECTION: Vascular Ultrasound ORIGINATOR: Deborah L. Richert, BSVT, RDMS, RVT DATE: October 15, 2015
More informationCase 8038 Renal allograft complicated with renal artery stenosis
Case 8038 Renal allograft complicated with renal artery stenosis Santiago I, Canelas A, Pinto AP Section: Cardiovascular Published: 2009, Nov. 30 Patient: 61 year(s), male Clinical History A 61-year-old
More information(J Exper Med 59: , 1934)
(J Exper Med 59:347-379, 1934) Goldblatt experiments Allowed the discovery of the renin-angiotensinaldosterone system -- Braun-Menendez: 'hypertensin' -- Bumpus: 'angiotonin' Angiotensin Led to surgical/interventional
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationCardiac Imaging Tests
Cardiac Imaging Tests http://www.medpagetoday.com/upload/2010/11/15/23347.jpg Standard imaging tests include echocardiography, chest x-ray, CT, MRI, and various radionuclide techniques. Standard CT and
More informationRENAL ARTERY PTA. JH PEREGRIN IKEM, Prague
RENAL ARTERY PTA JH PEREGRIN IKEM, Prague PTRA/Stenting PTRA technical success rate > 90 % In some patients helps control hypertension In some patients can improve kidney function Serious complications
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More information